20 LATEST RESOURCES (517 INDEXED)
Effect of Risperidone on Plasma Vascular Endothelial Growth Factor Levels in Patients with First-Episode Schizophrenia: A Preliminary Study · September 2023
Articles
Psychiatry Research Communications
Single Trajectory Treatment Response for Predominant Negative Symptoms: Post-Hoc Analysis of a Clinical Trial with Cariprazine and Risperidone · September 2023
Articles
Schizophrenia Research
Comparison of Aripiprazole and Risperidone Effectiveness in Treating Obsessive-Compulsive Disorder in Patients with Bipolar Disorder: Double-Blind, Randomized Clinical Trial · August 2023
Articles
Health Science Reports
Effects of Risperidone/Paliperidone versus Placebo on Cognitive Functioning Over the First 6 Months of Treatment for Psychotic Disorder: Secondary Analysis of a Triple-Blind Randomised Clinical Trial · June 2023
Articles
Translational Psychiatry
Metabolic Biomarkers of Risperidone-Induced Weight Gain in Drug-Naive Patients with Schizophrenia · April 2023
Articles
Frontiers in Psychiatry
Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety · April 2023
Articles
Neuropsychiatric Disease and Treatment
Successful Switching from Risperidone to Cariprazine in a Schizophrenic Patient with Pronounced Functional Deficit: Case Report · March 2023
Articles
Frontiers in Psychiatry
Longitudinal Multi-Omics Alterations Response to 8-Week Risperidone Monotherapy: Evidence Linking Cortical Thickness, Transcriptomics and Epigenetics · March 2023
Articles
Frontiers in Psychiatry
Treatment of Misophonia with Risperidone in a Patient with Autism Spectrum Disorder · September 2022
Articles
Case Reports in Psychiatry
Risperidone-Induced Changes in DNA Methylation in Peripheral Blood from First-Episode Schizophrenia Patients Parallel Changes in Neuroimaging and Cognitive Phenotypes · August 2022
Articles
Psychiatry Research
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study · August 2022
Articles
NCBI>Current Neuropharmacology
Antioxidant Enzymes and Weight Gain in Drug-Naive First-Episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study · August 2022
Articles
NCBI>Current Neuropharmacology
Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data from a Pragmatic Randomized Controlled Trial in Drug-Naive First-Episode Psychosis · May 2022
Articles
International Journal of Neuropsychopharmacology
Core Signs and Symptoms in Children with Autism Spectrum Disorder Improved after Starting Risperidone and Aripiprazole in Combination with Standard Supportive Therapies: A Large, Single-Center, Retrospective Case Series · May 2022
Articles
Brain Sciences
Can Pediatric Bipolar Disorder Be Successfully Treated When Comorbid with Conduct Disorder? A Secondary Analysis of Clinical Trials of Risperidone, Olanzapine, Quetiapine, Ziprasidone, and Aripiprazole · May 2022
Abstracts
Journal of Psychopharmacology
Association of Risperidone with Gastric Cancer: Triangulation Method from Cell Study, Animal Study, and Cohort Study · April 2022
Articles
Frontiers in Pharmacology
Effectiveness and Adverse Effects of Risperidone in Children with Autism Spectrum Disorder in a Naturalistic Clinical Setting at a University Hospital in Oman · January 2022
Articles
Autism Research and Treatment
A Double-Blind, Placebo-Controlled Trial of Bupropion Add-On to Olanzapine or Risperidone in Overweight Individuals with Schizophrenia · November 2021
Abstracts
Journal of Clinical Psychopharmacology
Characteristics of the Corpus Callosum in Chronic Schizophrenia Treated with Clozapine or Risperidone and Those Never-Treated · October 2021
Articles
BMC Psychiatry
The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study · October 2021
Articles
Drug Design, Development and Therapy